Accessible cancer drugs and OTC health products are provided by Das Oncocare.
Annual revenue $14,509 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Das Oncocare

Das Oncocare is a company. Das Oncocare offers products and services including Cancer Drugs and OTC Sprays.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Das Oncocare Pvt. Ltd
  • Jurisdiction Goregaon E Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $14.51 K (USD)
    11.07
    as on Mar 31, 2022
  • Net Profit
    -$39.18 K (USD)
    -15.7
    as on Mar 31, 2022
  • EBITDA
    -$48.34 K (USD)
    -33.62
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Das Oncocare

Das Oncocare offers a comprehensive portfolio of products and services, including Cancer Drugs and OTC Sprays.

Product name locked
Category locked
Primary

Latest cancer drugs and medicines are made accessible and affordable to support treatment needs.

Product name locked
Category locked
Locked

Sprays for sanitizing, pain relief, and wound care are provided to address everyday health concerns.

Funding Insights of Das Oncocare

Premium access

Detailed funding history for Das Oncocare

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Das Oncocare

Investments
Premium access

Investment portfolio details for Das Oncocare

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Das Oncocare

Premium access

Detailed financials for Das Oncocare

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Das Oncocare Comparisons

Das Oncocare Primary company
Description
Accessible cancer drugs and OTC health products are provided...
Location
-
Founded Year
-
Annual Revenue
$14.51 K (USD)
Net Profit
-$39.18 K (USD)
EBITDA
-$48.34 K (USD)
Employees
Not available
Premium access

Peer comparison for Das Oncocare

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Das Oncocare

Premium access

Detailed competitors of Das Oncocare

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Das Oncocare

Premium access

Complete news archive for Das Oncocare

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Das Oncocare

Annual revenue of Das Oncocare is $14.51K as on Mar 31, 2022.

Das Oncocare is recognized for making the latest cancer drugs and medicines accessible and affordable across various regions. Quality products, including OTC sprays for pain relief and wound care, are offered to meet essential health needs. Operations are registered in the Caribbean, Central America, and the Indian subcontinent, with a commitment to delivering effective therapies. The company emphasizes adherence to high standards in treatment trust, supported by its founders expertise in medicine. This focus ensures life-altering support when it is most needed.

Das Oncocare offers Cancer Drugs and OTC Sprays.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available